Blood glucose measurement in the intensive care unit: What is the best method?

Journal of Diabetes Science and Technology

Volumn 7, Issue 2, 2013, Pages 489-499

  Le, Huong T ^a   Harris, Neil S ^a   Estilong, Abby J ^a   Olson, Arvid ^a   Rice, Mark J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Central laboratory device; Cost; Critical care; Glucose; Point of care; Turnaround time

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE; GLUCOSE 6 PHOSPHATE; GLUCOSE DEHYDROGENASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; GLUCOSE BLOOD LEVEL;

BLOOD GAS ANALYZER; BLOOD GLUCOSE MEASUREMENT; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; BLOOD TRANSFUSION; CRITICALLY ILL PATIENT; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HUMAN; INSULIN TREATMENT; INTENSIVE CARE UNIT; LABORATORY DEVICE; LABORATORY TEST; LIMIT OF DETECTION; MEASUREMENT; MEASUREMENT ACCURACY; QUALITY CONTROL; REIMBURSEMENT; REVIEW; TURNAROUND TIME; BLOOD; COST; CRITICAL ILLNESS; DEVICES; ECONOMICS; HOSPITAL INFORMATION SYSTEM; HYPOGLYCEMIA; METHODOLOGY; PHYSIOLOGIC MONITORING; STANDARD; ANALYSIS; PROCEDURES; STANDARDS;

BLOOD GLUCOSE; COSTS AND COST ANALYSIS; CRITICAL ILLNESS; EQUIPMENT AND SUPPLIES; HUMANS; HYPOGLYCEMIA; INTENSIVE CARE UNITS; MONITORING, PHYSIOLOGIC; POINT-OF-CARE SYSTEMS;

EID: 84891444975     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681300700226     Document Type: Review

References (51)

1. Prisco L, Iscra F, Ganau M, Berlot G. Early predictive factors on mortality in head injured patients: a retrospective analysis of 112 traumatic brain injured patients. J Neurosurg Sci. 2012;56(2):131-6.
2. Chi A, Lissauer ME, Kirchofner J, Scalea TM, Johnson SB. Effect of glycemic state on hospital mortality in critically ill surgical patients. Am Surg. 2011;77(11):1483-9.
3. Murphy CV, Coffey R, Cook CH, Gerlach AT, Miller SF. Early glycemic control in critically ill patients with burn injury. J Burn Care Res. 2011;32(6):583-90.
4. Gianchandani RY, Esfandiari NH, Haft JW, Prager RL, Pop-Busui R. Diabetes and stress hyperglycemia in the intensive care unit: outcomes after cardiac surgery. Hosp Pract (Minneap). 2012;40(2):22-30.
5. Richards JE, Kaufmann RM, Obremskey WT, May AK. Stress-induced hyperglycemia as a risk factor for surgical-site infection in non-diabetic orthopaedic trauma patients admitted to the intensive care unit. J Orthop Trauma. 2013;27(1):16-21.
6. Tayek CJ, Tayek JA. Diabetes patients and non-diabetic patients intensive care unit and hospital mortality risks associated with sepsis. World J Diabetes. 2012;3(2):29-34.
7. Lazzeri C, Valente S, Chiostri M, Attanà P, Picariello C, Gensini GF. The glucose dysmetabolism in the acute phase of non-diabetic ST-elevation myocardial infarction: from insulin resistance to hyperglycemia. Acta Diabetol. 2011. Epub ahead of print.
8. American Diabetes Association. Standards of medical care in diabetes - 2008. Diabetes Care. 2008;31 Suppl 1:S12-54.
9. Rodbard HW, Blonde L, Braithwaite SS, Brett EM, Cobin RH, Handelsman Y, Hellman R, Jellinger PS, Jovanovic LG, Levy P, Mechanick JI, Zangeneh F; AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract. 2007;13 Suppl 1:1-68.
10. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449-61. (Pubitemid 43200296)
11. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359-67.
12. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283-97.
13. Mowery NT, Gunter OL, Kauffmann RM, Diaz JJ Jr, Collier BC, May AK. Duration of time on intensive insulin therapy predicts severe hypoglycemia in the surgically critically ill population. World J Surg. 2012;36(2):270-7.
14. D'Ancona G, Bertuzzi F, Sacchi L, Pirone F, Stringi V, Arcadipane A, Bellazzi R, Pilato M. Iatrogenic hypoglycemia secondary to tight glucose control is an independent determinant for mortality and cardiac morbidity. Eur J Cardiothorac Surg. 2011;40(2):360-6.
15. Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, Dhaliwal R, Henderson WR, Chittock DR, Finfer S, Talmor D. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180(8):821-7.
16. De Jonghe B, Appere-De-Vechi C, Fournier M, Tran B, Merrer J, Melchior JC, Outin H. A prospective survey of nutritional support practices in intensive care unit patients: what is prescribed? What is delivered? Crit Care Med. 2001;29(1):8-12. (Pubitemid 32125766)
17. Pitkin AD, Rice MJ. Challenges to glycemic measurement in the perioperative and critically ill patient: a review. J Diabetes Sci Technol. 2009;3(6):1270-81.
18. Bland JM, Altman DG. Applying the right statistics: analyses of measurement studies. Ultrasound Obstet Gynecol. 2003;22(1):85-93. (Pubitemid 36886457)
19. Stork AD, Kemperman H, Erkelens DW, Veneman TF. Comparison of the accuracy of the HemoCue glucose analyzer with the Yellow Springs Instrument glucose oxidase analyzer, particularly in hypoglycemia. Eur J Endocrinol. 2005;153(2):275-81 (Pubitemid 41167485)
20. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307-10. (Pubitemid 16134762)
21. Atkin SH, Dasmahapatra A, Jaker MA, Chorost MI, Reddy S. Fingerstick glucose determination in shock. Ann Intern Med. 1991;114(12):1020-4.
22. Tang Z, Du X, Louie RF, Kost GJ. Effects of pH on glucose measurements with handheld glucose meters and a portable glucose analyzer for point-of-care testing. Arch Pathol Lab Med. 2000;124(4):577-82. (Pubitemid 30210991)
23. Tang Z, Lee JH, Louie RF, Kost GJ. Effects of different hematocrit levels on glucose measurements with handheld meters for point-of-care testing. Arch Pathol Lab Med. 2000;124(8):1135-40. (Pubitemid 30650312)
24. Janssen W, Harff G, Caers M, Schellekens A. Positive interference of icodextrin metabolites in some enzymatic glucose methods. Clin Chem. 1998;44(11):2379-80. (Pubitemid 28511771)
25. Tang Z, Louie RF, Lee JH, Lee DM, Miller EE, Kost GJ. Oxygen effects on glucose meter measurements with glucose dehydrogenase- and oxidase-based test strips for point-of-care testing. Crit Care Med. 2001;29(5):1062-70. (Pubitemid 32424364)
26. Wong XW, Singh-Levett I, Hollingsworth LJ, Shaw GM, Hann CE, Lotz T, Lin J, Wong OS, Chase JG. A novel, model-based insulin and nutrition delivery controller for glycemic regulation in critically ill patients. Diabetes Technol Ther. 2006;8(2):174-90. (Pubitemid 43848040)
27. Kovatchev BP, Clarke WL, Breton M, Brayman K, McCall A. Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application. Diabetes Technol Ther. 2005;7(6):849-62. (Pubitemid 43133992)
28. Kilgore ML, Steindel SJ, Smith JA. Evaluating stat testing options in an academic health center: therapeutic turnaround time and staff satisfaction. Clin Chem. 1998;44(8 Pt 1):1597-603. (Pubitemid 28381199)
29. Howanitz PJ, Jones BA; College of American Pathologists. Comparative analytical costs of central laboratory glucose and bedside glucose testing: a College of American Pathologists Q-Probes study. Arch Pathol Lab Med. 2004;128(7):739-45. (Pubitemid 38856882)
30. Rinker G. Cost accounting applied to the clinical laboratory. Clin Lab Sci. 1995;8(6):339-42. (Pubitemid 26061765)
31. Foulke GE, Harlow DJ. Effective measures for reducing blood loss from diagnostic laboratory tests in intensive care unit patients. Crit Care Med. 1989;17(11):1143-5. (Pubitemid 19276535)
32. Burrin JM, Price CP. Measurement of blood glucose. Ann Clin Biochem. 1985;22(Pt 4):327-42. (Pubitemid 15058478)
33. Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, Lernmark A, Metzger BE, Nathan DM; National Academy of Clinical Biochemistry; Evidence-Based Laboratory Medicine Committee of the American Association for Clinical Chemistry. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care. 2011;34(6):e61-99.
34. Ricos C, Alvarez V, Cava F, Garcia-Lario JV, Hernandez A, Jimenez CV, Minchinela J, Perich C, Simon M. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest. 1999;59(7):491-500. (Pubitemid 30056739)
35. Baig A, Siddiqui I, Jabbar A, Azam SI, Sabir S, Alam S, Ghani F. Comparision between bed side testing of blood glucose by glucometer vs centralized testing in a tertiary care hospital. J Ayub Med Coll Abbottabad. 2007;19(3):25-9.
36. Personal communication with Neil S. Harris.
37. Bénéteau-Burnat B, Bocque MC, Lorin A, Martin C, Vaubourdolle M. Evaluation of the blood gas analyzer Gem PREMIER 3000. Clin Chem Lab Med. 2004;42(1):96-101. (Pubitemid 38401476)
38. Roche Diagnostics. Evaluation report of the ACCU-CHEK® Comfort Curve test strip as a plasma-like test strip. http://www.poc.roche.com/en-US/pdf/ Evaluation-Report001.pdf.
39. Gijzen K, Moolenaar DL, Weusten JJ, Pluim HJ, Demir AY. Is there a suitable point-of-care glucose meter for tight glycemic control? Evaluation of one home-use and four hospital-use meters in an intensive care unit. Clin Chem Lab Med. 2012;50(11):1985-92.
40. Krouwer JS, Cembrowski GS. A review of standards and statistics used to describe blood glucose monitor performance. J Diabetes Sci Technol. 2010;4(1):75-83.
41. Malone B. Blood glucose meters: is FDA ready to tighten up accuracy standards? Clinical Laboratory News. 2010;36(5). http://www.aacc.org/ publications/cln/2010/may/Pages/CoverStory1May2010.aspx#.
42. Tonyushkina K, Nichols JH. Glucose meters: a review of technical challenges to obtaining accurate results. J Diabetes Sci Technol. 2009;3(4):971-80.
43. Rao LV, Jakubiak F, Sidwell JS, Winkelman JW, Snyder ML. Accuracy evaluation of a new glucometer with automated hematocrit measurement and correction. Clin Chim Acta. 2005;356(1-2):178-83. (Pubitemid 40779900)
44. Wu P, Morey TE, Harris NS, Gravenstein N, Rice MJ. Intravenous fluids cause systemic bias in a conductivity-based point-of-care hematocrit meter. Anesth Analg. 2012;114(2):314-21.
45. Stahl M, Brandslund I, Jørgensen LG, Hyltoft Petersen P, Borch-Johnsen K, de Fine Olivarius N. Can capillary whole blood glucose and venous plasma glucose measurements be used interchangeably in diagnosis of diabetes mellitus? Scand J Clin Lab Invest. 2002;62(2):159-66. (Pubitemid 34407553)
46. Carstensen B, Lindström J, Sundvall J, Borch-Johnsen K, Tuomilehto J; DPS Study Group. Measurement of blood glucose: comparison between different types of specimens. Ann Clin Biochem. 2008;45(Pt 2):140-8. (Pubitemid 351724584)
47. Grek S, Gravenstein N, Morey TE, Rice MJ. A cost-effective screening method for preoperative hyperglycemia. Anesth Analg. 2009;109(5):1622-4.
48. Winkelman JW, Wybenga DR, Tanasijevic MJ. The fiscal consequences of central vs distributed testing of glucose. Clin Chem. 1994;40(8):1628-30. (Pubitemid 24241163)
49. Khan AI, Vasquez Y, Gray J, Wians FH Jr, Kroll MH. The variability of results between point-of-care testing glucose meters and the central laboratory analyzer. Arch Pathol Lab Med. 2006;130(10):1527-32. (Pubitemid 44520721)
50. Klonoff DC. Intensive insulin therapy in critically ill hospitalized patients: making it safe and effective. J Diabetes Sci Technol. 2011;5(3):755-67.
51. Diabetesnet.com. Comparison of current continuous glucose monitors (CGMs). http://www.diabetesnet.com/diabetes-technology/meters-monitors/ continuous-monitors/compare-current-monitors.